THE OFFICIAL
ONLY FROM REDWOOD MEDIA
A RATING
Hover over a menu item to access other pages
The Latest Paradigm Shift in Dental Implants
Redesigning the Standard of Care: Dr. James Grant and the Proximerge Solution “Treating the Cause to eliminate the Effect.”
For decades, the dental industry has accepted a flawed implant design as the norm. But Dr. James Grant, a Colorado-based clinical dentist and recognized thought leader in dentistry, decided that wasn’t good enough—for his patients or the future of oral systemic healthcare. With over 37 years of clinical practice, Dr. Grant has heard the same complaint again and again: food getting constantly trapped around dental implants. In 2007, he stopped accepting excuses and started creating a solution. Today, that solution is Proximerge—an FDA-cleared implant poised to disrupt and improve dentistry worldwide.
A Breakthrough Implant Born from Patient Frustration
Dr. Grant’s mission began after, yet another patient returned with the all-too-familiar frustration of food impaction around their implant. Determined to solve the problem of implant design, he threw out the decades-old playbook and took a fresh approach. That bold move ultimately led to the formation of Quadric BioMed Inc., headquartered in Colorado Springs, Colorado.
While partnering with Dr. Brad Renehan, an oral-maxillofacial surgeon trained at The Mayo Clinic as well as Aaron Bass (CEO), a seasoned executive with a strong background in compliance and team leadership, a clinical solution emerged—Proximerge, the world’s first and only rectangular dental implant. (Figure 1) Unlike traditional round implants that leave problematic gaps, Proximerge mimics the natural anatomy of the tooth being replaced, dramatically improving form, function, and improved oral hygiene.
FIGURE 1
Solving the 50-Year Implant Problem
For over five decades, the same issue has plagued implant dentistry: food impaction. Traditional round implants—designed in the 1980s—fail to fill the rectangular spaces left by a missing tooth. The gaps they leave behind not only trap food, but also create breeding grounds for bacteria, leading to inflammation, damaged adjacent teeth (Figure 2.) and toxins entering the blood system associated with diabetes, heart disease, Alzheimer’s, rheumatoid arthritis and many other oral systemic diseases. It's the number one complaint among patients, and a recurring headache for dentists, hygienists, and dental labs alike.
"Every implant on the market—regardless of brand—is a variation of the same flawed design, replacing a multirooted molar with a single implant screw” says Dr. Grant. “Our solution is simple; we redesigned the shape to match that of the molar tooth being replaced."
With a rectangular form that mirrors the extracted tooth, Proximerge eliminates gaps, food traps and reduced bacteria. Patients get natural outcomes, not a “toadstool” crown. (Figure 3.) Dentists reduce costly follow-ups. Labs avoid remakes. Hygienists effectively clean bacteria away from the tissue. And the entire care team benefits from greater patient satisfaction and increased referrals.
FIGURE 2
FIGURE 3
From Proof of Concept to Global Demand
The Proximerge implant is more than theory—it’s clinically proven. Over 100 patients already have Proximerge implants in place, with tremendous success. According to Dr. Grant, the protocol is nearly identical to traditional methods, using a proprietary set of patented instruments and techniques. The process is easily adopted and cost-equivalent with increased patient satisfaction and oral health.
“Patients have asked us to remove their old implants just to replace them with Proximerge,” says Dr. Grant. “That’s how profound the difference is.”
Dentists are just as excited. During a lecture with a major dental lab group, Dr. Grant recalls the chairman standing up just ten minutes in and saying, “Dr. Grant, you don’t have to go any further. We needed this yesterday. We have only one question: How soon can we get it?”
Quadric BioMed: Innovation at Every Level
Founded in 2010, Quadric BioMed Inc. was built with one goal: to solve dentistry’s toughest challenges through innovation. Today, the company is a fully integrated operation, leveraging U.S.-based manufacturing to ensure quality and scalability. The facility in Scottsdale, Arizona, serves as a production lab, and soon will utilize two new state-of-the-art training centers recently launched in Colorado.
Led by a team of clinical and business veterans, the company holds eight issued U.S. patents, with more filings underway. Quadric BioMed has also achieved FDA clearance for Proximerge and secured key regulatory certifications, including ISO and CE marks. Sterilization, packaging, and production pipelines are already active, with capacity ready to expand.
Dr. Grant shares. “Dr. Renehan and I have dedicated years to improve the oral/systemic health of all. Now everything is in place—it’s time to scale.”
Positioned for a Market Ready to Erupt
The timing couldn’t be better. The global dental implant market is valued at $5.1 billion in 2025 and projected to hit $8.17 billion by 2032. With a 6.9% CAGR, the industry is being driven by an aging population, increasing oral health awareness, and rising rates of tooth loss from gum disease and decay. Implants remain the gold standard for tooth replacement—but they’ve needed innovation. Proximerge delivers that innovation. It represents a disruptive solution—one that patients, providers, and labs have been waiting for and is poised to offer a market solution on one else can.
A Call to Partners and Investors
“We’re thrilled by the enthusiasm for Proximerge from consumers and the dental community here and across the globe. We share their excitement and anticipation for our full, market-wide rollout. We’re looking forward to joining with investors or partners who share our vision to provide the opportunity to ramp-up production.”
With the technology validated, regulatory paths cleared, and infrastructure in place, Quadric BioMed is ready for its next chapter—and the right strategic partner for this disruptive technology in a robust dental market.
Connect with Quadric BioMed
Investors, dental professionals, and industry leaders who want to be part of the next major advancement in implantology are encouraged to reach out. For more information or partnership opportunities, contact Dr. James Grant or CEO Aaron Bass directly.
Dr. James Grant
Founder and Chief Dental Officer
Quadric BioMed Inc.
Email: j.grant@quadricbiomed.com
Websites: https://www.quadricbiomed.com / https://www.proximerge.com
LinkedIn: www.linkedin.com/in/jimgrantdds